CD40 mod 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OPT101 / Op-T
NCT06964087: Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Not yet recruiting
2
72
NA
OPT101, OPT101 Placebo to Match (PTM)
Op-T LLC
Type I Diabetes
05/26
08/28
NCT04589403: 1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.

Recruiting
1
15
US
OPT101, 15-mer peptide
Op-T LLC
Healthy
06/24
06/24
NCT05428943: OPT101 in Type 1 Diabetes Patients

Completed
1
22
US
OPT101
Op-T LLC
Diabetes Mellitus, Type 1
02/24
02/24
NCT06669403: OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

Not yet recruiting
1
26
US
OPT101, Placebo, Placebeo
Op-T LLC
Sepsis, Community Acquired Pneumonia (CAP)
04/26
05/26
S95041 / Servier
No trials found
Adze-1.17-CD40L / Adze Biotech
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OPT101 / Op-T
NCT06964087: Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Not yet recruiting
2
72
NA
OPT101, OPT101 Placebo to Match (PTM)
Op-T LLC
Type I Diabetes
05/26
08/28
NCT04589403: 1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.

Recruiting
1
15
US
OPT101, 15-mer peptide
Op-T LLC
Healthy
06/24
06/24
NCT05428943: OPT101 in Type 1 Diabetes Patients

Completed
1
22
US
OPT101
Op-T LLC
Diabetes Mellitus, Type 1
02/24
02/24
NCT06669403: OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

Not yet recruiting
1
26
US
OPT101, Placebo, Placebeo
Op-T LLC
Sepsis, Community Acquired Pneumonia (CAP)
04/26
05/26
S95041 / Servier
No trials found
Adze-1.17-CD40L / Adze Biotech
No trials found

Download Options